Our R&D portfolio for paediatric HIV
What we have achieved
Our research is helping countries replace older, difficult–to–use, and sometimes ineffective formulations and scale up new, optimum treatments for young children.
What we are doing for children living with HIV
Our engagement goes well beyond drug development alone. Through a series of partnerships, we are working to ensure improved treatments for kids are rolled out where they are needed most.
Building capacity, uniting expertise
Research platforms and consortiums that bring together researchers and strengthen research capacities in low- and middle-income countries are central to our virtual R&D model.
Partnering for patients
Collaboration is an essential part of how we work. We have forged a diverse range of alliances and research collaborations with over 200 partners in nearly 50 countries.
Get our latest news, personal stories, research articles, and job opportunities.